“Pharnext Pleotherapy Approach in Orphan Neuropathies”

In Clinical Development, Featured on App, Orphan Drug Congress by Freya SmaleLeave a Comment

Xavier Paoli of Pharnext  joined us for World Orphan Drug Congress USA 2015 to present about ‘ Pharnext Pleotherapy Approach in Orphan Neuropathies’ 
Download the presentation now to learn more about:
  • R&D process
  • R&D paradigm: pleotherapy
  • CMT1A: Slow progressive peripheral neuropathy
  • PXT-3003 for the treatment of CMT1A
…and much more!
Get your copy here!
To find out more about how PXT-3003 can aid in the treatment of CMT1A , join us at World Orphan Drug Congress USA 2016 April 20-22  in Washington, DC.

Leave a Comment